Delivery Order SPE2DR25D1017-SPE2DR26F9BPM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Aprepitant 40 mg capsule unit dose packages in quantities of 5. This competitively awarded, non-set-aside contract carries a ceiling value of $10,195.38 and operates under firm fixed pricing terms, with an ultimate completion date of November 4, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $7,623.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules (6-count units) on December 12, 2025, with completion scheduled for December 15, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,086.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packaging (six-count). This order was competitively awarded without set-aside designation and carries a firm fixed price contract type, with an ultimate completion date of November 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $4,229.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules with a ceiling value of $1,842.89. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,618.63 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit-dose packaging. The contract, executed on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 125-80-80 mg pharmaceutical packs, valued at $1,226.10, with completion targeted for December 16, 2025. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child delivery order issued under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,247.16 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (quantity 6). This non-set-aside, firm fixed price delivery order was awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order operates under...
- The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BPMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six units. This is a firm fixed-price contract with a ceiling value of $24,166.47 and an ultimate completion date of December 17, 2025. The contract is not set-aside and represents a competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities. The company's federal contracting history demonstrates consistent capability to meet DLA procurement requirements through competitive awards across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 12/15/25 |